SC 13G/A

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Company: Actinium Pharmaceuticals, Inc.
Filed: February 13, 2018
Accession Number: 0000921895-18-000530

View Document ↗ View on SEC.gov ↗